MRI-first strategy for prostate cancer detection proves to be safe, study finds Active monitoring is a sufficiently safe option when prostate MRI findings are negative Date: December 20, 2024 ...

New AI model detects and grades prostate cancer with 89% accuracy using MRI, cutting reliance on invasive biopsies and ...

Microultrasonography-guided prostate biopsy proved noninferior to MRI/conventional ultrasound-fusion (MRI/US-fusion) imaging for detecting clinically significant cancer, a large randomized trial ...

New Corewell Health™ research suggests an MRI scan can help predict whether patients with intermediate-risk prostate cancer (cancer confined to the entire prostate) may have more aggressive ...

Adding an indication for prostate cancer diagnosis has the potential to significantly expand the U.S. market for Telix’s twin commercial PSMA-PET imaging agents by approximately 800,000 scans 7.

New research suggests that review of current prostate cancer screening guidelines may be needed, as MRI frequently fails to detect cancer-indicative lesions, even in men with elevated PSA levels.

This comprehensive guide provides essential information to help patients and their families navigate their prostate cancer ...

With MRI-guided stereotactic body radiation planning, radiation oncologists could help minimize radiation to pivotal structures involved in erectile function, new data suggest.

Nonalcoholic fatty liver disease (NAFLD) is a key driver of insulin resistance and high blood sugar, both contributing to and ...

Covera's Prostate Imaging COE will be automatically activated in early 2026 for employer and health plan partners already using Covera's Radiology Centers of Excellence platform.

Microultrasonography-guided prostate biopsy proved noninferior to MRI/conventional ultrasound-fusion (MRI/US-fusion) imaging for detecting clinically significant cancer, a large randomized trial ...